Literature DB >> 21424933

Plectin deficiency on cytoskeletal disorganization and transformation of human liver cells in vitro.

Yi-Hsiang Liu1, Chiung-Chi Cheng, Chin-Chin Ho, Wei-Ting Chao, Ren-Jeng Pei, Yung-Hsiang Hsu, Lu-Chang Ho, Bei-Hao Shiu, Yih-Shyong Lai.   

Abstract

Plectin is a versatile cytoplasmic cross-linking protein that connects intermediate filaments to microfilaments, microtubules, and membrane adhesion sites. The cross-linking functions of plectin help organize the cytoskeleton into a stable meshwork important for maintaining uniformity in cell size and shape. As cells of hepatocellular carcinoma are morphologically different from normal human hepatocytes, we hypothesized that altered plectin expression and cytoskeletal organization underlies this pleomorphic transformation. To test this hypothesis, we analyzed expression levels and organization of all cytoskeletal elements, including intermediate filaments, microfilaments, and microtubules, after plectin knockdown in human Chang liver cells. We found that expression of cytokeratin 18, but not actin or tubulin, was downregulated by suppression of plectin protein. Furthermore, cytokeratin networks were partially collapsed and actin-rich stress fibers were increased. The organization of microtubule networks, by contrast, was unaltered. These findings support our hypothesis that, via effects on cytoskeletal organization, plectin deficiency might play an important role in the transformation of human liver cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21424933     DOI: 10.1007/s00795-010-0499-y

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  24 in total

1.  Plectin deficiency results in muscular dystrophy with epidermolysis bullosa.

Authors:  F J Smith; R A Eady; I M Leigh; J R McMillan; E L Rugg; D P Kelsell; S P Bryant; N K Spurr; J F Geddes; G Kirtschig; G Milana; A G de Bono; K Owaribe; G Wiche; L Pulkkinen; J Uitto; W H McLean; E B Lane
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

Review 2.  The cytoskeleton of the hepatocyte. Structure and functions.

Authors:  G Feldmann
Journal:  J Hepatol       Date:  1989-05       Impact factor: 25.083

3.  Regulation of actin synthesis in rat hepatocytes by cytoskeletal rearrangements.

Authors:  K H Reuner; P Dunker; A van der Does; M Wiederhold; I Just; K Aktories; N Katz
Journal:  Eur J Cell Biol       Date:  1996-02       Impact factor: 4.492

4.  Cytokeratin intermediate filaments of rat hepatocytes: different cytoskeletal domains and their three-dimensional structure.

Authors:  Y Katsuma; N Marceau; M Ohta; S W French
Journal:  Hepatology       Date:  1988 May-Jun       Impact factor: 17.425

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Identification of the cytolinker plectin as a major early in vivo substrate for caspase 8 during CD95- and tumor necrosis factor receptor-mediated apoptosis.

Authors:  A H Stegh; H Herrmann; S Lampel; D Weisenberger; K Andrä; M Seper; G Wiche; P H Krammer; M E Peter
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

7.  The influence of plectin deficiency on stability of cytokeratin18 in hepatocellular carcinoma.

Authors:  Chiung-Chi Cheng; Yi-Hsiang Liu; Chin-Chin Ho; Wei-Ting Chao; Ren-Jeng Pei; Yung-Hsiang Hsu; Kun-Tu Yeh; Lu-Chang Ho; Ming-Chuang Tsai; Yih-Shyong Lai
Journal:  J Mol Histol       Date:  2007-11-24       Impact factor: 2.611

8.  Dual Role of alpha6beta4 integrin in epidermal tumor growth: tumor-suppressive versus tumor-promoting function.

Authors:  Karine Raymond; Maaike Kreft; Ji-Ying Song; Hans Janssen; Arnoud Sonnenberg
Journal:  Mol Biol Cell       Date:  2007-08-15       Impact factor: 4.138

9.  Plectin deposition at podosome rings requires myosin contractility.

Authors:  Annica Gad; Sibylle Lach; Luca Crimaldi; Mario Gimona
Journal:  Cell Motil Cytoskeleton       Date:  2008-08

10.  Could the cytokeratin molecule be modulated during tumor transformation in hepatocellular carcinoma?

Authors:  B Su; R J Pei; K T Yeh; Y H Hsu; Y S Lai
Journal:  Pathobiology       Date:  1994       Impact factor: 4.342

View more
  6 in total

Review 1.  Cytokeratin 18-associated Histone 3 Modulation in Hepatocellular Carcinoma: A Mini Review.

Authors:  Yen-Chang Clark Lai; Chiung-Chi Cheng; Yih-Shyong Lai; Yi-Hsiang Liu
Journal:  Cancer Genomics Proteomics       Date:  2017 Jul-Aug       Impact factor: 4.069

Review 2.  The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence.

Authors:  Tamsin Wesley; Stuart Berzins; George Kannourakis; Nuzhat Ahmed
Journal:  Cell Commun Signal       Date:  2021-05-17       Impact factor: 5.712

3.  Transient knockdown-mediated deficiency in plectin alters hepatocellular motility in association with activated FAK and Rac1-GTPase.

Authors:  Chiung-Chi Cheng; Yen-Chang Clark Lai; Yih-Shyong Lai; Yung-Hsiang Hsu; Wei-Ting Chao; Kee-Chin Sia; Yu-Hui Tseng; Yi-Hsiang Liu
Journal:  Cancer Cell Int       Date:  2015-03-07       Impact factor: 5.722

4.  Plectin deficiency in liver cancer cells promotes cell migration and sensitivity to sorafenib treatment.

Authors:  Chiung-Chi Cheng; Wei-Ting Chao; Chen-Chun Liao; Yu-Hui Tseng; Yen-Chang Clark Lai; Yih-Shyong Lai; Yung-Hsiang Hsu; Yi-Hsiang Liu
Journal:  Cell Adh Migr       Date:  2017-02-17       Impact factor: 3.405

5.  Liver transcriptome profiling and functional analysis of intrauterine growth restriction (IUGR) piglets reveals a genetic correction and sexual-dimorphic gene expression during postnatal development.

Authors:  Hongmei Gao; Longchao Zhang; Ligang Wang; Xin Liu; Xinhua Hou; Fuping Zhao; Hua Yan; Lixian Wang
Journal:  BMC Genomics       Date:  2020-10-08       Impact factor: 3.969

Review 6.  Plectin in Cancer: From Biomarker to Therapeutic Target.

Authors:  Samantha M Perez; Lindsey T Brinton; Kimberly A Kelly
Journal:  Cells       Date:  2021-08-30       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.